Gonzalez-Martin A, Chung HC, Saada-Bouzid E, Yanez E, et al. Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study. Gynecol Oncol 2024;186:182-190.
PMID: 38718741